Pharmaceuticals

The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers unique insight into the use, safety and effectiveness of blood thinners prasugrel and clopidogrel in hospitals across the United States. 

September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug-eluting stent (DES) implantation demonstrated that six weeks of drug therapy was not superior to six months of therapy with regard...

AstraZeneca announced it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial that tested the safety and effectiveness of the blood thinner ticagrelor (Brilinta)....

Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world’s first T-cel...

Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. At least 65 percent of people with diabetes die from...
October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its investigational heart failure medicine,...
Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating and preventing heart failure. The newly...
Twelve-month Data St. Jude Medical EnligHTN Renal Denervation System
St. Jude Medical Inc. announced 12-month outcome data from the EnligHTN III study, which demonstrated a continuation of safe, rapid and effective treatment...
Zontivity (vorapaxar) tablets reduce the risk of heart attack, stroke, cardiovascular death and need for procedures to restore the blood
Atherotech Diagnostics Lab offers warfarin sensitivity, Plavix sensitivity and thrombophilia risk tests. The warfarin and Plavix...
Liptruzet (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K...

Articles

Study Blood Thinner Heart Attack Patients
The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers unique insight into the use, safety and effectiveness of blood...
September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug-eluting stent (DES) implantation...
August 28, 2014 — Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical...
U.S. Department of Justice Close Investigation PLATO Clinical Trial Ticagrelor
AstraZeneca announced it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical...

Video Center

By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
5 weeks 15 hours ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
8 weeks 2 days ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
14 weeks 17 hours ago
This webinar will discuss why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...

Comparison Charts

Sorry there is no data available